Molecular Space Construction: NeoVentures Biotechnology’s Aptamarker platform leverages Aptamarker analysis to construct a molecular space, where individuals cluster based on unique biomolecular profiles. This space captures diversity in responses to diseases and allows for the nuanced exploration of different pathophysiological processes leading to the same… Read More »Aptamarkers as the Compass for Patient Stratification
Immune Tolerance Advantage of Aptamarkers: Aptamarkers overcome immune tolerance issues in traditional antibody development. Aptamarkers vs. Antibodies: A Quantitative Advantage: Broader recognition spectrum aligns the biomarker landscape in animal models more closely with the human context. Training Aptamarkers in Animal Trials: Aptamarkers can be trained… Read More »Aptamarker: Breaking Barriers – Animal Trials to Human Trials
NeoVentures Biotechnology’s Aptamarker platform revolutionizes clinical trials by introducing personalized and predictive inclusion and exclusion criteria. Aptamarkers are trained using biological samples and participants’ treatment responses, enabling a cost-effective qPCR test for screening individuals entering clinical trials. The predictive capabilities of Aptamarkers allow researchers to… Read More »Aptamarker Use Case: Enhancing Clinical Trials with Aptamarker Precision – Tailoring Inclusion and Exclusion Criteria
English 
French 
Spanish